logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

41T60/41U61
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Product Categories:

Pharmaceutical Ingredients, Food Additives and Ingredients, Food Ingredients, Sweeteners, Functional Food

Products:

L-Arabinose: A naturally occurring sugar with applications in food, pharmaceuticals, and nutraceuticals.

D-Xylose: A sugar used as a precursor for xylitol production and in various biochemical applications.

Xylitol: A sugar alcohol used as a sweetener in food products, offering dental benefits and a low glycemic index.

L-Ribose: A rare sugar utilized in pharmaceutical synthesis and health supplements.

2-Deoxy-L-Ribose: A sugar derivative important in biochemical research and pharmaceutical applications.

Xylooligosaccharide: A prebiotic fiber promoting beneficial gut bacteria, used in functional foods and supplements.

Healtang Biotech Co., Ltd.(济南圣泉唐和唐生物科技有限公司)is a specialized biotechnology company based in Jinan, China, focused on the extraction, purification, and application of functional sugars and rare carbohydrates. With a strong foundation in fermentation and separation technologies, Healtang is a leading global supplier of specialty monosaccharides, sugar alcohols, and prebiotic fibers, serving industries such as food and beverage, pharmaceuticals, nutraceuticals, and biotechnology.

Core Business

Healtang Biotech’s core business is the research, development, and commercial production of high-purity bio-based sugars, with applications ranging from natural sweeteners to pharmaceutical intermediates. The company integrates raw material processing, biotransformation, and fine chemical separation to produce ingredients with high functional and commercial value.

Product & Service Offerings

The company’s product line includes:

  • L-Arabinose

    • Naturally sourced from corn fiber; functions as a low-glycemic sugar with regulatory benefits in carbohydrate digestion
    • Used in functional beverages, low-calorie foods, and diabetic-friendly formulations
  • D-Xylose

    • A key precursor for xylitol production and intermediate in biochemical processes
    • Applied in flavor enhancers, Maillard reaction systems, and as a fermentation substrate
  • Xylitol

    • A sugar alcohol with a low glycemic index and anti-cariogenic properties
    • Commonly used in chewing gum, dental care products, and diabetic food lines
  • L-Ribose

    • A rare sugar used in pharmaceutical APIs and cardioprotective health supplements
    • Offers support for ATP replenishment and cellular energy metabolism
  • 2-Deoxy-L-Ribose

    • Important in DNA synthesis pathways and as a reagent in pharmaceutical and biochemical research
  • Xylooligosaccharide (XOS)

    • A potent prebiotic fiber promoting the growth of Bifidobacteria
    • Incorporated in functional food, yogurt, dietary supplements, and gut health formulations

Healtang supports customized specifications, including mesh size, purity grades, and packaging formats for B2B buyers.

Specialisation and Core USP

The company’s specialization lies in:

  • Advanced enzymatic hydrolysis and separation technologies
  • Production of rare and value-added sugars from renewable plant biomass
  • Proven scale-up capacity for both common and novel carbohydrate molecules
  • Deep experience with food-grade, pharmaceutical-grade, and research-grade standards

Its USP is its capability to offer a full spectrum of pentose and hexose derivatives, including those with limited global supply.

Financials and Operational Scale

Operating as a subsidiary under Shandong Shengquan Group, Healtang benefits from significant industrial backing:

  • Estimated annual revenue: USD 15–25 million
  • Manufacturing facilities cover over 20,000 square meters
  • Annual production capacities:
    • L-Arabinose: 2,000+ MT
    • Xylooligosaccharide: 3,000+ MT
    • Xylitol and derivatives: 5,000+ MT
  • Exports to over 50 countries across Europe, Southeast Asia, North America, and the Middle East

Shipment and Export Data

According to industry platforms and trade databases:

  • Over 120 recorded international shipments between 2020 and 2024
  • Major export destinations: Germany, South Korea, India, USA, Indonesia
  • Primary exports: L-Arabinose, XOS, and D-Xylose
  • Shipment values per container: USD 12,000–50,000, depending on volume and purity

The company offers OEM labeling, bulk export packaging, and flexible MOQs for international clients.

Target Market

  • Nutraceutical companies producing functional foods and supplements
  • Pharmaceutical manufacturers requiring rare sugar intermediates
  • Food and beverage producers formulating with low-GI or prebiotic ingredients
  • Cosmetic and personal care brands seeking sugar-derived actives
  • Biotech labs and research institutes

Healtang serves clients both directly and via global distribution partners.

Capabilities

  • Fermentation and enzymatic bioconversion systems
  • Industrial-scale chromatographic purification and crystallization
  • R&D labs for structure-function analysis and application testing
  • Full traceability and batch record management
  • Support for custom development of new sugar molecules and derivatives

The company collaborates with universities and national research centers for innovation in carbohydrate biochemistry.

Certifications and Compliance

  • ISO 9001:2015 Quality Management
  • HACCP Certified
  • Halal and Kosher Certification
  • Products meet requirements of GB (China), EU Food Additive Regulation (EFSA), and US FDA GRAS
  • Documentation includes COA, MSDS, TDS, and analytical method support

Regulatory support is available for global product registration and compliance dossiers.

Customer Testimonials

Feedback from international buyers consistently notes:

  • High product purity and batch consistency
  • Competitive pricing in the rare sugar category
  • Responsive technical and logistics coordination
  • Reliable lead times for bulk and contract orders

Customers in the EU dietary supplement sector report excellent gut health outcomes from XOS and consistent performance of L-Arabinose in blood sugar control formulas.

Major Achievements

  • Recognized as a Key Export-Oriented Biotech Enterprise by the Jinan Municipal Government (2021)
  • Awarded National High-Tech Enterprise Certification
  • Developed proprietary production lines for L-Ribose and 2-Deoxy-L-Ribose
  • Participated in China-EU Biotech Ingredient Collaboration Program
  • Filed multiple patents on xylo-based oligosaccharide production processes

Healtang Biotech Co., Ltd. continues to lead in rare sugar innovation, providing scalable, sustainable, and science-backed ingredient solutions to the world’s food, health, and pharmaceutical industries.